Company Profiles

driven by the PitchBook Platform

AMURA

Description

Developer of protease inhibitors. The company operates a drug discovery business specializing in diseases such as osteoporosis, osteoarthritis, bone metastasis, autoimmunity, chronic pain and malaria.

2005

Founded

PRIVATE

Status

11-50

Employees

Later Stage VC

Latest Deal Type

5

Investors

Description

Developer of protease inhibitors. The company operates a drug discovery business specializing in diseases such as osteoporosis, osteoarthritis, bone metastasis, autoimmunity, chronic pain and malaria.

Website:

www.amura.co.uk

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Other Healthcare Technology Systems

Primary Office

Highfield Court Church Lane, Madingley Cambridgeshire CB23 8AGEngland +44 (0)19 5421 1515
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore AMURA's full profile, request a free trial.

    AMURA Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    AMURA Investors (5)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Avlar BioVenturesVenture CapitalMinority000 0000000 0000
    BeringeaPE/BuyoutMinority000 0000000 0000
    Noble Fund ManagersInvestment BankMinority000 0000000 0000
    Sitka PartnersVenture CapitalMinority000 0000000 0000
    Touchstone InnovationsVenture CapitalMinority000 0000000 0000
    Avlar BioVentures Venture Capital
    Beringea PE/Buyout
    Noble Fund Managers Investment Bank
    Sitka Partners Venture Capital
    Touchstone Innovations Venture Capital

    AMURA Executive Team (3)

    NameTitleBoard
    Seat
    Contact
    Info
    Nick FlinnHead of Preclinical Development
    Daniel Roach Ph.DBoard Member & General Manager
    David Brown Ph.DExecutive Chairman
    Nick Flinn Head of Preclinical Development
    Daniel Roach Ph.D Board Member & General Manager
    David Brown Ph.D Executive Chairman

    AMURA Board Members (4)

    NameRepresentingRoleSinceContact
    Info
    Alan GoodmanAvlar BioVenturesChief Executive Officer & Director, Finance000 0000
    Daniel Roach Ph.DSelfBoard Member & General Manager000 0000
    David Brown Ph.DSelfExecutive Chairman000 0000
    Steven TuckleyBeringeaChief Financial Officer000 0000
    Alan Goodman Chief Executive Officer & Director, Finance Avlar BioVentures
    Daniel Roach Ph.D Board Member & General Manager Self
    David Brown Ph.D Executive Chairman Self
    Steven Tuckley Chief Financial Officer Beringea
    Request full access to PitchBook